BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32911909)

  • 21. Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis.
    Lin ZY; Wang LY; Yu ML; Chen SC; Chuang WL; Hsieh MY; Tsai JF; Chang WY
    J Gastroenterol Hepatol; 2000 Apr; 15(4):417-21. PubMed ID: 10824887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Ye X; Li C; Zu X; Lin M; Liu Q; Liu J; Xu G; Chen Z; Xu Y; Liu L; Luo D; Cao Z; Shi G; Feng Z; Deng H; Liao Q; Cai C; Liao DF; Wang J; Jin J; Cao D
    Hepatology; 2019 Jun; 69(6):2489-2501. PubMed ID: 30672601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of serum abnormal prothrombin in clinical application of hepatocellular carcinoma].
    Zhang JW; Guan LY; E CY; Yang JH; Xuan W; Meng ZH; Li W
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):776-781. PubMed ID: 32993265
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
    An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.
    Shi BM; Lu W; Ji K; Wang YF; Xiao S; Wang XY
    World J Gastroenterol; 2017 May; 23(20):3713-3720. PubMed ID: 28611524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Lamin B1, Vimentin and Anti-Ku86 as Prospective Biomarkers of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection.
    Idriss NK; Fakhry M; Imam HM; Abd-Elmoez FA; Abdelewahab H; Abdel-Wahid L; Abbas WA; Abozaid MAA; Sayed Z; Ashmawy AM
    Cell Physiol Biochem; 2019; 52(3):595-605. PubMed ID: 30897324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
    Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
    Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
    Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
    Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
    BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma.
    Attallah AM; El-Far M; Abdel Malak CA; Farid K; Omran MM; Yahya RS; Saad EA; Albannan MS; Attallah AA; El Basuni MA; Ali IS; Abed SB; El Naggar MA
    Ann Hepatol; 2015; 14(6):869-80. PubMed ID: 26436359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.